SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TITAN PHARMACEUTICAL (TTP) -- Ignore unavailable to you. Want to Upgrade?


To: Alfred W. Post who wrote (120)2/19/2000 2:52:00 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 362
 
Hi There!

How is wether in Swiss. Lot of snow?

<<You must know that Novartis is a Swiss firm with worldwide insterests. London is more interntional than Basel.>>

I like more Basel, regardless that was never there.

<<I bought into Titan Pharm. when I read that Novartis is cooperating with them. My reasoning is simple: I guess that if a large firm like Novatis teems up with little Titan, than they must know that Titan is promissing.>>

Me too. Not TTP (not at that time), but Iloperidone was big hope for Novartis.

<<And I was right.>>

Surelu You are.

<<When I bought Titan it sold for $3.50 and look at it now. I jusst sent Norartis an e-mail and told them that they should do as well as TTP (While Novartis increased earnings by 11% the performance of its stock is lousy) I also told themtey couldmerge with Titan, why not!!!.>>

Next time when you send e-mail to Novartis, please mention SI biofreaks who are big supporter of TTP and Novartis.

<<Rumers have it that they are trying to list their shares in NY.>>

It is almost done.

<<your Fred Post from Switzerland>.

Best from CA and LA.

Miljenko